80 related articles for article (PubMed ID: 11847428)
1. Profile of genes showing increased expression following dopamine and methamphetamine exposure in an immortalized neuronal cell line.
Cai NS; McCoy MT; Cadet JL
Restor Neurol Neurosci; 2001; 18(2-3):57-65. PubMed ID: 11847428
[TBL] [Abstract][Full Text] [Related]
2. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
3. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
4. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: evidence from cDNA array.
Cadet JL; Jayanthi S; McCoy MT; Vawter M; Ladenheim B
Synapse; 2001 Jul; 41(1):40-8. PubMed ID: 11354012
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death.
Kanthasamy A; Anantharam V; Ali SF; Kanthasamy AG
Ann N Y Acad Sci; 2006 Aug; 1074():234-44. PubMed ID: 17105920
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced spectrin proteolysis in the rat striatum.
Staszewski RD; Yamamoto BK
J Neurochem; 2006 Mar; 96(5):1267-76. PubMed ID: 16417574
[TBL] [Abstract][Full Text] [Related]
7. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
8. A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells.
Niwa M; Nitta A; Cen X; Kitaichi K; Ozaki N; Yamada K; Nabeshima T
J Neurochem; 2008 Dec; 107(6):1697-708. PubMed ID: 19014384
[TBL] [Abstract][Full Text] [Related]
9. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
10. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
[TBL] [Abstract][Full Text] [Related]
13. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage.
Kuhn DM; Francescutti-Verbeem DM; Thomas DM
Ann N Y Acad Sci; 2006 Aug; 1074():31-41. PubMed ID: 17105901
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
15. Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity.
Asanuma M; Miyazaki I; Higashi Y; Tsuji T; Ogawa N
Ann N Y Acad Sci; 2004 Oct; 1025():69-75. PubMed ID: 15542702
[TBL] [Abstract][Full Text] [Related]
16. Serial analysis of gene expression in the rat striatum following methamphetamine administration.
Cai NS; McCoy MT; Ladenheim B; Lyles J; Ali SF; Cadet JL
Ann N Y Acad Sci; 2006 Aug; 1074():13-30. PubMed ID: 17105900
[TBL] [Abstract][Full Text] [Related]
17. [Alteration of neuronal activities following repeated administration of stimulants].
Amano T; Matsubayashi H; Sasa M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
[TBL] [Abstract][Full Text] [Related]
18. mRNA expression of the Nurr1 and NGFI-B nuclear receptor families following acute and chronic administration of methamphetamine.
Akiyama K; Isao T; Ide S; Ishikawa M; Saito A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1957-66. PubMed ID: 18930103
[TBL] [Abstract][Full Text] [Related]
19. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
